The drug, used to treat toxoplasmosis infection, became the subject of notoriety in 2015 when manufacturer Turing Pharmaceuticals, then led by Shkreli, raised the price from $13.50 to $750 per pill, making it a poster child for the issue of high drug prices.
San Diego's Imprimis Pharmaceuticals could give Martin Shkreli a run for his money - offering an alternative to the egregiously high cost Daraprim at $1 a pill.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Martin Shkreli attracted a legion of negative attention from the masses thanks to his drug price hikes - and less-than-winsome persona. But can we learn something from this?